RYAN BARBARA sold 6.8% of their position (1.50K shares) of MINK THERAPEUTICS, INC. on the open market
Open‑market sale worth $22.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 3/11/2026ACC: 0001193125-26-102581
-1.50K
Net shares
Net seller
$22.1K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
1.50K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−200.00
Price / share
$10.17
Trade value
$2.03K
% of position
0.9%
3/9/2026
21.91K→21.71K
Common Stock
Direct
Shares
−300.00
Price / share
$15.28
Trade value
$4.58K
% of position
1.4%
3/10/2026
21.71K→21.41K
Common Stock
Direct
Shares
−500.00
Price / share
$15.57
Trade value
$7.78K
% of position
2.3%
3/10/2026
21.41K→20.91K
Common Stock
Direct
Shares
−500.00
Price / share
$15.30
Trade value
$7.65K
% of position
2.4%
3/10/2026
20.91K→20.41K
Total
Net shares
−1.50K
Net value
-$22.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/9/2026 | S · Sale | −200.00 | $10.17 | $2.03K | 0.9% | 21.91K | 21.71K |
| Common Stock Direct | 3/10/2026 | S · Sale | −300.00 | $15.28 | $4.58K | 1.4% | 21.71K | 21.41K |
| Common Stock Direct | 3/10/2026 | S · Sale | −500.00 | $15.57 | $7.78K | 2.3% | 21.41K | 20.91K |
| Common Stock Direct | 3/10/2026 | S · Sale | −500.00 | $15.30 | $7.65K | 2.4% | 20.91K | 20.41K |
| Total | −1.50K | -$22.05K | ||||||
Derivative Transactions0
No derivative transactions reported